| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,463 |
11,708 |
$734K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
999 |
863 |
$61K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
525 |
500 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
669 |
605 |
$44K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
497 |
474 |
$43K |
| 93000 |
|
2,525 |
2,386 |
$30K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
770 |
664 |
$26K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
2,570 |
2,196 |
$23K |
| 99497 |
|
402 |
382 |
$20K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
61 |
60 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,200 |
1,093 |
$11K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,872 |
1,825 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
604 |
579 |
$7K |
| 90756 |
|
346 |
306 |
$6K |
| 99401 |
|
273 |
225 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
132 |
112 |
$3K |
| 96127 |
|
766 |
753 |
$3K |
| 90688 |
|
230 |
226 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
82 |
76 |
$3K |
| 87428 |
|
38 |
38 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
82 |
82 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
72 |
65 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
72 |
57 |
$1K |
| 90661 |
|
66 |
58 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
406 |
363 |
$751.97 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
187 |
141 |
$597.03 |
| 90686 |
|
35 |
35 |
$532.62 |
| 94060 |
|
12 |
12 |
$503.57 |
| 99442 |
|
60 |
53 |
$441.51 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
25 |
20 |
$435.90 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14 |
12 |
$305.68 |
| G0008 |
Administration of influenza virus vaccine |
117 |
111 |
$302.73 |
| 3008F |
|
13,325 |
9,683 |
$30.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
37 |
27 |
$21.36 |
| 99072 |
|
236 |
200 |
$15.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,383 |
1,132 |
$0.00 |
| 4004F |
|
112 |
111 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
13,689 |
10,676 |
$0.00 |
| 3078F |
|
2,553 |
2,060 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
39 |
35 |
$0.00 |
| 3077F |
|
289 |
241 |
$0.00 |
| 1124F |
|
160 |
140 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
47 |
47 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
13 |
13 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
38 |
37 |
$0.00 |
| 99490 |
Ccm add 20min |
41 |
41 |
$0.00 |
| 3074F |
|
3,501 |
2,722 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
46 |
46 |
$0.00 |
| 3079F |
|
1,959 |
1,616 |
$0.00 |
| 3044F |
|
566 |
537 |
$0.00 |
| 3075F |
|
836 |
695 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,485 |
1,191 |
$0.00 |
| 1036F |
|
2,955 |
2,675 |
$0.00 |
| 3080F |
|
46 |
40 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
24 |
24 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
76 |
74 |
$0.00 |
| G8732 |
No documentation of pain assessment, reason not given |
28 |
28 |
$0.00 |
| J3490 |
Unclassified drugs |
13 |
13 |
$0.00 |
| 3014F |
|
50 |
47 |
$0.00 |